JP2014516535A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014516535A5 JP2014516535A5 JP2014511946A JP2014511946A JP2014516535A5 JP 2014516535 A5 JP2014516535 A5 JP 2014516535A5 JP 2014511946 A JP2014511946 A JP 2014511946A JP 2014511946 A JP2014511946 A JP 2014511946A JP 2014516535 A5 JP2014516535 A5 JP 2014516535A5
- Authority
- JP
- Japan
- Prior art keywords
- ferritin
- iron
- disorder
- yeast
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/114,429 US8778878B2 (en) | 2007-01-29 | 2011-05-24 | Use of ferritin to treat iron disorders |
| US13/114,429 | 2011-05-24 | ||
| PCT/GB2012/000461 WO2012160333A2 (en) | 2011-05-24 | 2012-05-24 | Recombinant yeast |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014516535A JP2014516535A (ja) | 2014-07-17 |
| JP2014516535A5 true JP2014516535A5 (cg-RX-API-DMAC7.html) | 2015-07-02 |
Family
ID=46317426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014511946A Pending JP2014516535A (ja) | 2011-05-24 | 2012-05-24 | 組換え酵母 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8778878B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2714888B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2014516535A (cg-RX-API-DMAC7.html) |
| CN (1) | CN103635570A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012260682B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112013029769B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2874042C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2714888T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2659185T3 (cg-RX-API-DMAC7.html) |
| NO (1) | NO2714888T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL2714888T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012160333A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10249552A1 (de) | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
| PT1973549T (pt) | 2006-01-06 | 2016-10-25 | Luitpold Pharm Inc | Métodos e composições para administração de ferro |
| US8778878B2 (en) * | 2007-01-29 | 2014-07-15 | Chyna, LLC | Use of ferritin to treat iron disorders |
| US20170273906A1 (en) * | 2014-08-21 | 2017-09-28 | Ramot At Tel-Aviv University Ltd. | Targeted liposomes encapsulating iron complexes and their uses |
| KR101811050B1 (ko) * | 2015-09-02 | 2017-12-21 | 경북대학교 산학협력단 | 항염증성 폴리펩티드와 페리틴 모노머 단편이 접합된 융합폴리펩티드 및 이를 유효성분으로 포함하는 염증성 질환 예방 및 치료용 약학적 조성물 |
| CN108503704A (zh) * | 2017-02-27 | 2018-09-07 | 昆山新蕴达生物科技有限公司 | 穿越血脑屏障的纳米药物载体 |
| CN112533616A (zh) * | 2018-06-04 | 2021-03-19 | 赛德罗生物科学有限责任公司 | 改善铁代谢和肠道微生物组健康的组合物和方法 |
| WO2020239809A1 (en) * | 2019-05-28 | 2020-12-03 | Previpharma Consulting Gmbh | Method for preparing iron-depleted ferritin and use thereof |
| CN110759986B (zh) * | 2019-10-18 | 2023-01-31 | 大连工业大学 | 一种可逆自组装蛋白的高效制备方法 |
| CN117642083A (zh) * | 2021-05-19 | 2024-03-01 | 赛德罗生物科学有限责任公司 | 铁蛋白组合物耐受性 |
| KR102691733B1 (ko) * | 2021-10-13 | 2024-08-05 | 전북대학교산학협력단 | 효모 유래 액포를 유효성분으로 포함하는 퇴행성 신경계 질환의 예방 또는 치료용 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100419530B1 (ko) * | 2000-11-15 | 2004-02-19 | 주식회사 알엔에이 | 재조합 메탄올 자화 효모를 이용한 인간 페리틴의 대량생산 방법 |
| KR100545981B1 (ko) * | 2003-04-08 | 2006-01-25 | 전북대학교산학협력단 | 이종중합형 패리틴 생산방법 |
| FR2898132B1 (fr) * | 2006-03-01 | 2012-09-28 | Mane Fils V | Systeme d'expression d'un gene d'interet chez la levure |
| US8071542B2 (en) * | 2007-01-29 | 2011-12-06 | Chyna, LLC | Use of ferritin to treat iron deficiency disorders |
| US8778878B2 (en) * | 2007-01-29 | 2014-07-15 | Chyna, LLC | Use of ferritin to treat iron disorders |
| EP2265113B1 (en) * | 2008-03-28 | 2014-07-16 | Chyna Llc | Use of ferritin to treat iron deficiency disorders |
-
2011
- 2011-05-24 US US13/114,429 patent/US8778878B2/en active Active
-
2012
- 2012-05-24 PL PL12727897T patent/PL2714888T3/pl unknown
- 2012-05-24 WO PCT/GB2012/000461 patent/WO2012160333A2/en not_active Ceased
- 2012-05-24 CN CN201280024378.4A patent/CN103635570A/zh active Pending
- 2012-05-24 DK DK12727897.6T patent/DK2714888T3/da active
- 2012-05-24 JP JP2014511946A patent/JP2014516535A/ja active Pending
- 2012-05-24 BR BR112013029769-7A patent/BR112013029769B1/pt active IP Right Grant
- 2012-05-24 ES ES12727897.6T patent/ES2659185T3/es active Active
- 2012-05-24 NO NO12727897A patent/NO2714888T3/no unknown
- 2012-05-24 CA CA2874042A patent/CA2874042C/en active Active
- 2012-05-24 AU AU2012260682A patent/AU2012260682B2/en active Active
- 2012-05-24 EP EP12727897.6A patent/EP2714888B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014516535A5 (cg-RX-API-DMAC7.html) | ||
| O'Shea et al. | Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid | |
| JP2015057451A5 (cg-RX-API-DMAC7.html) | ||
| JP2013535437A5 (cg-RX-API-DMAC7.html) | ||
| HK1204272A1 (en) | Methods of treating pediatric metabolic syndrome | |
| IL232764A (en) | Fluoromethyl6,5 - Dihydro - 4 H - [3,1] Oxazines, Pharmaceuticals Containing Them and Their Use in the Preparation of Medicines to Treat Alzheimer's Disease | |
| CN110088102A (zh) | 一种含氮杂环类化合物、其制备方法、药物组合物及应用 | |
| CA2923685A1 (en) | Application of r-ketamine and salt thereof as pharmaceuticals | |
| JP2014510704A5 (cg-RX-API-DMAC7.html) | ||
| JP2014507482A5 (cg-RX-API-DMAC7.html) | ||
| JP2014523851A5 (cg-RX-API-DMAC7.html) | ||
| WO2012080727A3 (en) | Casein kinase 1delta (ck1delta) inhibitors | |
| UA109991C2 (xx) | Карбаматні сполуки, їх отримання і застосування | |
| JP2016503398A5 (cg-RX-API-DMAC7.html) | ||
| WO2013158928A3 (en) | Chemosensory receptor ligand-based therapies | |
| WO2013061004A8 (fr) | Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines | |
| NZ700374A (en) | New therapeutic approaches for treating parkinson’s disease | |
| MX2013008056A (es) | 1,4-oxazepinas como inhibidores de beta-secretasa 1 (bace1) y/o beta-secretasa 2 (bace2). | |
| JP2014506890A5 (cg-RX-API-DMAC7.html) | ||
| JP2014198723A5 (cg-RX-API-DMAC7.html) | ||
| JP2016510326A5 (cg-RX-API-DMAC7.html) | ||
| JP2016534081A5 (ja) | ゾレドロン酸の増強された経口バイオアベイラビリティーを有する経口剤形を調製する方法 | |
| JP2013541583A5 (cg-RX-API-DMAC7.html) | ||
| HRP20210361T1 (hr) | Upotreba pripravka koji sadrži gliceril-tribenzoat kod neurodegenerativnih poremećaja | |
| HK1206347A1 (en) | Cyclohexane-1,2'-naphthalene-1',2"-imidazole compounds and their use as bace inhibitors |